Status:
COMPLETED
Motion Sickness Medications and Vestibular Time Constant
Lead Sponsor:
Medical Corps, Israel Defense Force
Conditions:
Drug Reaction
Eligibility:
MALE
18-40 years
Phase:
PHASE4
Brief Summary
Sea sickness represents a major limitation on the performance of ships' crew. One of the challenges faced by the physician in the motion sickness clinic when prescribing anti-sea sickness medication i...
Eligibility Criteria
Inclusion
- Healthy soldiers between the ages of 18 to 40, who suffering from sea sickness
- 48 hours prior to session without any use of medications
- Soldiers who vomit in waves 1.5 meter high without drugs treatment
Exclusion
- Anamnestic hearing Impairment
- Ear infection of any kind
- Pathological finding in an otoneurological examination, witch will be done by a trained neurophysiologist / a physician. In any case of pathological finding, patient will be advised to continue medical assesment.
- Vision pathologies the interfere with VNG test.
- Withdrawal of informed consent by the patient of any cause.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03270839
Start Date
June 1 2017
End Date
January 1 2020
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Israeli Navy Medical Institute
Haifa, Israel